Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Saudi Med J ; 43(7): 694-699, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35831000

ABSTRACT

OBJECTIVES: To elucidate the link between fetuin-A expression in human umbilical vein endothelial cells (HUVECs) and amnion cells (ACs) and clinicopathological changes in patients with gestational diabetes mellitus (GDM) and newborns. METHODS: This retrospective cohort study included 82 pregnant patients (40 with GDM and 42 controls) between January 2019 and January 2022. The patients underwent a one-hour, 50 gram glucose challenge test (GCT) during the 24-28th weeks of pregnancy. Patients with positive GCTs immediately underwent a 3-hour, 100 gram oral glucose tolerance test. The expression level of fetuin-A in UVECs and ACs was evaluated by immunohistochemistry (IHC) and scored based on IHC staining in randomly selected slides. The IHC staining intensity was evaluated by the number of dots, which reflects the expression level of fetuin-A in both HUVECs and ACs. RESULTS: The GDM group displayed significantly higher fetuin-A expression in both HUVECs (p<0.0001) and ACs (p=0.0001) when compared with the control group. Fetuin-A expression in HUVECs was correlated with fetal macrosomia, neonatal hypoglycemia, and placental weight. However, there was no correlation with fetuin-A expression in ACs. CONCLUSION: There is a correlation between fetal macrosomia, neonatal hypoglycemia, placental weight, and fetuin-A expression of HUVECs in patients with GDM.


Subject(s)
Diabetes, Gestational , Hypoglycemia , Amnion , Female , Fetal Macrosomia , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Infant, Newborn , Placenta/metabolism , Pregnancy , Retrospective Studies , alpha-2-HS-Glycoprotein/metabolism
2.
Saudi Med J ; 42(3): 255-263, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33632903

ABSTRACT

OBJECTIVES: To investigate the fibrinogen/albumin ratio (FAR) of pregnant women with abortus imminens (AI) and its prognostic value for predicting spontaneous abortion. METHODS: A total 102 early pregnancies, 52 had been diagnosed with AI and 50 ages and body mass index matched healthy control pregnant women were included in this prospective observational study conducted in the Research and Training Hospital, Balikesir University, Balikesir, Turkey between September 2019 and August 2020. Fibrinogen/albumin values were compared between AI and control group. RESULTS: The rate of spontaneous abortion in AI pregnancies was 26.9% in our study population. Fibrinogen/albumin ratio levels were higher in AI pregnancies than in controls (p=0.0088). The regression analysis have shown that the increased FAR value (odds ratio [OR]: 7.3116 [95% CI: 1.3119 to 40.7507]; p=0.0232) was an independent marker for spontaneous abortion prediction in AI pregnancies. CONCLUSION: Pregnancies with AI have increased levels of FAR compared to healthy pregnancies. Fibrinogen/albumin ratio is an independent marker for predicting spontaneous abortion.


Subject(s)
Abortion, Spontaneous/diagnosis , Abortion, Threatened/diagnosis , Fibrinogen/metabolism , Serum Albumin/metabolism , Abortion, Spontaneous/etiology , Abortion, Threatened/etiology , Adult , Biomarkers/blood , Female , Humans , Predictive Value of Tests , Pregnancy , Prognosis , Prospective Studies , Turkey
SELECTION OF CITATIONS
SEARCH DETAIL
...